Polaryx Therapeutics, Inc. (NASDAQ:PLYX) Given Average Recommendation of "Moderate Buy" by Brokerages
MarketBeat
Polaryx Therapeutics, Inc. (NASDAQ:PLYX - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the five analysts that are presently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, one has given a hold rating, two ha
NASDAQ:PLYX